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The acquisition of mutations plays critical roles in adaptation, evolution, senescence and 
tumorigenesis. Massive genome sequencing has allowed extraction of specific features of 
many mutational landscapes but it remains difficult to retrospectively determine the 
mechanistic origin(s), selective forces and trajectories of transient or persistent mutations and 
genome rearrangements. Here, we conducted the prospective reciprocal approach to inactivate 
13 single or multiple evolutionary-conserved genes involved in distinct genome maintenance 
processes  and characterize de novo mutations in 274 diploid S. cerevisiae mutation 
accumulation lines. This approach revealed the diversity, complexity and ultimate uniqueness 
of mutational landscapes, differently composed of base substitutions, small InDels, structural 
variants and/or ploidy variations. Several landscapes parallel the repertoire of mutational 
signatures in human cancers while others are either novel or composites of sub-signatures 
resulting from distinct DNA damage lesions. Notably, the increase of base substitutions in the 
homologous recombination deficient Rad51 mutant, specifically dependent on the Pol  
translesion polymerase, yields COSMIC Signature 3 observed in BRCA1/BRCA2-mutant 
breast cancer tumors. Furthermore, “mutome” analyses in highly polymorphic diploids and 
single-cell bottleneck lineages revealed a diverse spectrum of loss-of-heterozygosity (LOH) 
signatures characterized by interstitial and terminal chromosomal events resulting from inter-
homolog mitotic crossovers. Following the appearance of heterozygous mutations, the strong 
stimulation of LOHs in the rad27/FEN1 and tsa1/PRDX1 backgrounds leads to fixation of 
homozygous mutations or their loss along the lineage. Overall, these “Mutomes” and their 
trajectories provide a mechanistic framework to understand the origin and dynamics of 
genome variations that accumulate during clonal evolution.  
 




Deficiencies in genome maintenance genes result in increased mutagenesis and genome 
rearrangements that impacts cell viability, species adaptation and evolvabilty. The 
accumulation of somatic mutations is also a landmark of most tumor cells but it remains 
difficult to retrospectively determine their mechanistic origin(s). Here, we conducted the 
prospective reciprocal approach to inactivate evolutionary-conserved genes involved in 
various genome maintenance processes and characterize de novo mutations in diploid S. 
cerevisiae mutation accumulation lines. Our results revealed the diversity, trajectory, 
complexity and ultimate uniqueness of the clonal mutational landscapes. Some mutational 
signatures ressemble those found in human tumors.  
 
Introduction 
Acquired and transitory mutations, broadly genome instability, can be evolutionary 
advantageous in contributing to the adaptation of species in changing environments, or 
detrimental in reducing short- and long-term fitness (1–3). Mechanistically, spontaneous 
mutations in normal cells, exposure to environmental genotoxic compounds and deficiencies 
in genome maintenance genes are prominent sources of subtle or drastic genome 
changes/rearrangements and eventually functional and phenotypic variations (4, 5). A 
paradigm for this phenomenon is the accumulation of a variable burden of passenger and 
driver somatic mutations in tumor cell lineages (6–11). Thus, genome sequencing and 
mutational landscape analyses of germline and somatic mutations have permitted the 
retrospective identification of the most likely environmental sources of mutagen exposures, 
such as UV exposure in melanoma and smoking in lung cancers or genetic features such as 
deficiency in DNA mismatch repair in colon cancers  and homologous recombination defects 
in breast and ovarian cancers (6–14). However, it remains puzzling that in numerous 
instances, an environmental factor and/or defective mutator gene(s) is not found, although 
numerous relevant and evolutionary conserved genome maintenance genes and pathways are 
known (5, 15, 16). Here, we conducted the reciprocal functional approach to inactivate one or 
several genes involved in distinct genome maintenance processes (replication, repair, 
recombination, oxidative stress response or cell cycle progression) in S. cerevisiae diploids, 
establish the genome-wide mutational landscapes of mutation accumulation (MA) lines, 
explore the underlying mechanisms and characterize the dynamics of mutation accumulation 
(and disappearance) along single-cell bottleneck passages.  
 
Results and Discussion 
Variety of mutational landscapes 
Overall, we established the mutational landscapes of 274 MA lines generated in the isogenic 
BY and/or hybrid SK1/BY wild-type (WT) backgrounds. Strains assessed included wild-type 
(WT), 11 single deletion mutants (hereafter abbreviated by gene name) and 3 double-mutants 
covering various genome maintenance processes. Compared with WT, we analysed the 
following mutant strains: pif1Δ, pol32  and rad27  (replication), msh2  (mismatch repair), 
mre11Δ, rad51Δ, tho2Δ (recombination and repair), lig4Δ (Non-Homologous End Joining,  
tsa1Δ (oxidative stress response), cac1Δ cac3Δ (nucleosome deposition), clb5Δ and sic1Δ 
(cell cycle progression) (http://www.yeastgenome.org). The strain genotypes are indicated in 
Dataset S1. All the genes assessed are evolutionary conserved and most are implicated in 
human diseases and/or tumor development (Fig. 1A) (http://www.yeastgenome.org, 
http://www.genecards.org/). To ensure the recovery of independent events, 4-16 individual 
colonies per strain were derived in parallel MA lines (Fig. 1B), and sequenced after a 
minimum of 180 single-cell bottleneck passages (SI Appendix, Materials and Methods, 
Dataset S2 for individual clones). One passage corresponds to ~25 generations. Our 
bioinformatics analyses of the next-generation sequencing (NGS) reads allowed identification 
of base substitutions (SNPs), multi-nucleotide polymorphisms (MNPs), small (1-44 bp) 
insertions/deletions (InDels), combinations of SNP and small InDels (Complex), structural 
variants (SVs), as well as chromosomal ploidy variations and LOH regions (SI Appendix, 
Materials and Methods, SI Appendix,  Fig. S1). The coordinates and annotations of the 8,876 
de novo mutations identified in this study are reported in Datasets 3 to 8. The number of 
mutations detected in the parallel MA lines of the same genotype was similar (SI Appendix, 
Fig. S2A and Dataset S9), thus excluding clonal effects. Except for few common 
homopolymer InDels in msh2 and rad27 backgrounds, all mutations were different from one 
another.  
Functionally, 4,103/5,416 (75.8%) base substitutions were located in a gene-coding region 
(Datasets 3 and 4), similar to random expectation (76.5%). At the protein level, 2,879 (53.2%) 
modified the amino acid with a presumptive moderate functional impact according to SnpEff 
annotation (17), and 199 (3.7%) created a premature stop codon. Among these protein 
truncating mutations, 58 were located in an essential gene (https://www.yeastgenome.org/) 
and all were heterozygous, likely phenotypically recessive. 
        The mutation frequencies per strain genotype (normalized per clone and passage) are 
reported in Fig. 1C. Both BY and SK1/BY wild-type strains accumulated few SNPs 
corresponding to a frequency of 0.11 mutations/clone/passage or 1.8 × 10-10 
mutations/nucleotide/generation, similar to previous measurements (18). Not surprisingly, the 
vast majority were heterozygous (allelic ratio of ~0.5) but a few appeared as homozygous (see 
below). The mutation frequencies and genome rearrangements in the mutant MA lines varied 
up to 83-fold compared to WT (Fig. 1C; Dataset S10), and delineated 6 classes of mutational 
profiles. The first class, comprising cac1 cac3 (chromatin assembly factors), lig4 (non-
homologous end-joining) and pol32 (Pol  replication) accumulated few base substitutions, 
similar to WT (Fig. 1C). The second class represented by rad51 (homologous recombination) 
and tsa1 (oxidative stress) specifically increased base substitutions (20.5- and 13.6-fold, 
respectively) but seemingly via different mechanisms (see below). Distinctively, rad51 more 
than tsa1 (2.8 x 10-2 and 0.2 x 10-2 SV/clone/passage, respectively) enhanced structural 
variations (SVs). All were heterozygous intra-chromosomal deletions (Dataset S8). Their 
length varied between 488-59,200 nt and most particularly (11/17 cases) occurred between 
transposable (Ty/LTR) elements and the others between repeated homeologous genes 
(Dataset S8). This is typical of single-strand annealing (SSA) events, known to be Rad51-
independent (19).  The third class is defined by msh2 (mismatch repair) that exhibited a strong 
increase of base substitutions (26.4-fold) and small InDels (495-fold) with a slight excess 
(58.7%) of small InDels over base substitutions, as previously observed (20, 21). Notably, as 
reported for haploid strains (22, 23), there was an excess (81%) of deletions vs. additions 
within homopolymer tracks. Among all small variants, the complex base substitutions were 
rare (9/2824) (Fig. 1C; Dataset S10). The fourth class of mutant represented by clb5 and sic1 
(cell cycle progression), mre11 (double-strand break repair), and tho2 (transcription coupled 
recombination) exhibited a slight increase (1.5- to 3.6-fold) of base substitutions but also 
aneuploidies. The fifth class, defined by rad27 (lagging strand replication and base excision 
repair) yielded the broadest spectrum of mutational events. It exhibited an increase of base 
substitutions (8.1-fold increase) including few complex substitutions events (76/1208), small 
InDels (63-fold increase) mostly located in homopolymers and microsatellites (518/564) with 
an excess of insertion vs. deletion (73%) but also SVs represented by 26 large deletions (62-
23,614 nt)  and 2 small duplications (520 and 542 bp) (Dataset S8) as well as aneuploidies 
(7.8 fold increase) (Dataset S10). Similar to rad51, the SVs in rad27 reached a spontaneous 
frequency of 4.3 10-2/clone/passage. The deletions involved homeologous repeated regions 
located in cis but fewer (3/26 in rad27 instead of 11/17 in rad51) involved Ty/LTR elements 
(Dataset S8). The sixth class of mutational profile is represented by pif1, affecting various 
DNA metabolism functions (SGD, http://www.yeastgenome.org), whose major feature is the 
rapid and complete loss of mitochondrial DNA (SI Appendix, Fig. S2B). Further, pif1∆ MA 
lines exhibit a slight increase of base substitutions (2.5-fold) (Figure 1 and Dataset S10),  
consistent with the 2 to 3-fold increase of spontaneous mutagenesis previously observed in 
WT cells lacking mitochondrial DNA (rho0) (24). Compared to our previous analyses of 
haploid mutants (23), the mutational spectrum and the overall frequencies of SNPs and small 
Indels per genome in the haploid and diploid cells are similar (SI Appendix, Fig. S3) 
indicating no drastic effect of the ploidy variation.  
To more broadly characterize all the mutational landscapes, we also examined variation of 
mitochondrial DNA (mtDNA) and ribosomal DNA (rDNA) copy number. It was substantially 
variable in the WT and mutant parental strains with 0 to 103 mtDNA copies and 42 to 122 
rDNA copies. In the MA lines, slight changes of mitochondrial DNA and rDNA copy number 
(~20 copies) occurred from clone to clone (SI Appendix, Fig. S2B and C), compared with 
parent. lig4 clones increased and mre11 clones decreased median copy number of mtDNA (34 
and 40 copies, respectively). The study of additional MA lines issued from independent 
parental strains, preferentialy with variable amount of starting mtDNA, would be required to 
conclude if this is a mutant-specific effect, as observed in other yeast mutants (25) and 
determine its impact on mutational profiles. In summary, this set of mutator profiles illustrates 
a variety of mutator behaviours, leading to a considerable variety of mutation loads and 




The landscape of somatic mutations in tumor genomes has been correlated with distinct 
mutational processes, via mathematical and statistical methods able to distinguish different 
mutation signatures (6, 12, 14, 26–28). It has allowed identification of >30 cancer-derived 
patterns called COSMIC signatures, (http://cancer.ac.uk/cosmic/signatures) based on the 
relative incidences of base substitution changes within a trinucleotide context (12, 26). 
Similarly, we established the base substitution profile of our yeast mutants that yielded ≥500 
SNP mutations (Fig. 2A) and the relative contribution of the “COSMIC” signatures (Fig. 2B). 
tsa1, one of the strongest single-gene mutant mutator in yeast (29),  doesn’t exhibit a 
predominant signature but a near equal contribution of Signatures 1, 3, 9, 18 and 30 (Fig. 2B). 
Thus, loss of Tsa1 – the major thioredoxin peroxidase that scavenges hydrogen peroxide in S. 
cerevisiae (30) – which yielded C>A and C>T mutations was not associated with a specific 
COSMIC signature. Mutations in the human ortholog gene PRDX1 has not been associated 
with disease or tumors, perhaps due to extensive functional redundancy of thioredoxin 
peroxidases in mammals (31). Robustly, the msh2 signature (C>T, C>A and T>C) 
supplemented with homopolymers/microsatellite instability was most similar to Signatures 14 
and 20 (Fig. 2B), consistent with MMR-deficient cancer-derived signatures associated with 
elevated rates of colorectal and uterine cancers. Our analysis of the msh2  base substitutions 
identified by Lujan et al. (21) yielded a similar mutational signature (Fig. 2B). By contrast, 
rad27 exhibits Signature 8 associated with breast cancer and medulloblastoma 
(https://cancer.sanger.ac.uk/signatures/). Since, rad27 yields all kinds of mutational events 
(Fig. 1C-D) including a large spectrum of base substitutions (Fig. 2A), Signature 8 might be 
the sum of several lesion-specific sub-signatures. On the other hand, the rad51 profile 
predominantly involving C>A, C>G and C>T changes exhibited Signature 3 (Fig. 2B) 
consistent with its prominent role in homologous recombination (32).  Also differently, our 
analyses of the base substitutions in the mutator DNA polymerase mutants  pol1-L868M, 
pol2-M644G and pol3-L612M (21) yielded the predominant signatures 8, 22 and 12, 
respectively (SI Appendix, Fig. S4).  Altogether, these results outline the uniqueness of the 
base substitutions signatures to specific genes, and retrospectively inform on the molecular 
defects underlying the accumulation of mutations in specific tumors  (6–15). 
 
Base substitution in the absence of Rad51 specifically requires Pol  
Several decades ago, the elevated mutagenesis of a rad51 mutant was found to decrease when 
cells were also mutated in REV3 (33), a gene now known to encode a component of the error-
prone translesion synthesis (TLS) Rev1/Rev3/Rev7 polymerase  (zeta) complex (34). To 
further explore rad51 mutagenesis, we associated the rad51 deletion with each TLS 
polymerase deletion mutant, and measured mutation frequencies with the sensitive CAN1R 
mutational assay (35). This revealed that rad51 enhanced mutagenesis was reduced 
essentially to WT levels in combination with rev1, rev3 or rev7 but remained unchanged with 
pol4 (Pol ) or rad30 (Pol ) (Fig. 2C). Consistently, we did not find significant additive or 
synergic effects of combining rad51 with the rev1 rev3 pol4 rad30 quadruple mutant.  
Since,  Rev3 carries the catalytic activity of Pol  while the Rev1 and Rev7 proteins might 
also serve as “recruitment platforms” involved in other related but distinct biological 
functions - the mammalian REV7 is involved in controlling DNA end resection and DNA 
damage responses via the Shieldin complex (36–38) - we also combined rad51 with the 
catalytically dead rev3-D1142A,D144A polymerase mutant (39). rad51-induced mutagenesis 
was reduced to the WT level (Fig. 2C), demonstrating a role for Rev3 TLS activity. Thus, 
Pol appeared specifically involved in the default repair of DNA lesions in the absence of 
Rad51-dependent homologous recombination, most likely during replication. As Pol  is 
evolutionary conserved (40), these results raise the possibility that Pol  is responsible for 
enhanced mutational loads observed in HR-deficient BRCA1/2 mammalian cells, as well as in 
patients with RAD51 mutations and Fanconi anemia-like phenotypes (41). 
 For comparison, we also combined rev3 with the other base-substitution mutators. We 
found no reduction of CAN1R cells in the tsa1 background, indicating that Rad52 foci 
accumulating in this mutant (42) result from a different lesion(s) than in the rad51 setting. In 
contrast, the inactivation of REV3 yielded a partial decrease (58%) of CAN1R cells when 
combined with rad27 (Fig. 2C), suggesting that its deficiency in Okazaki fragment processing 
during lagging strand replication generates DSBs and/or single-strand gaps similar to rad51. 
The remaining Rev3-independent base substitution mutations may result from default base 
excision repair of apurinic/apyrimidinic (AP) sites (43), thus partially contributing to the 
composite Signature 8. Finally, similar to tsa1, the lack of Pol   had no discernible effect on 
msh2 mutagenesis (Fig. 2C). In conclusion, Pol  genetic dependency appears specifically 
connected to formation and/or resolution of lesions arising in a HR-deficient context.   
 
Occurrence of homozygous de novo mutations  
Beyond heterozygous mutations, we found some base substitutions and InDels with an allelic 
ratio of 1.0, implying loss of the wild-type allele. This mostly occurred in the msh2, tsa1 and 
rad27 diploids, representing 2.3%, 6.6%, and 13.4% of the total frequency of base 
substitutions and small indels mutations, respectively (Fig. 3A, Dataset S10). In such 
situations, various types of genomic events, distinguishable by the state of the homologous 
chromosomes, could be invoked (Fig. 3B). In msh2, 70/71 cases occurred in full diploid cells 
and resulted from two identical (18 cases) or two distinct (48 cases) InDels, located within the 
same homopolymer tract on the homologs (Fig. 3A, Datasets 3 and 6). It can be explained 
from the >1 nucleotide length of these motifs and high rate of polymerase slippage within 
homopolymers during replication (44). In tsa1, the homozygous SNPs were also mostly found 
on chromosomes with 2 copies (54/60 cases) but all were located in non-repeated nucleotide 
sequences (Fig. 3A, Datasets 3 and 4). This was rather similar in rad27, except that 22/163 
cases were associated with a change of the local copy number (1 or >2). We hypothesize that 
along the lineages, the heterozygous de novo mutations were rendered homozygous upon a 
subsequent LOH event. 
 
Detection of LOH signatures in hybrid yeasts 
LOH can result from mitotic inter-homolog recombination, short tract mitotic gene 
conversions and/or break-induced replication (BIR) events that are difficult to detect in 
isogenic strains. To comprehensively detect LOHs, we generated additional WT and mutant 
MA lines from the polymorphic SK1/BY diploid that carries >53,000 constitutive SNPs 
markers, distributed on each chromosome with one marker every 218 bp in average (Dataset 
S11). Compared to the isogenic and hybrid WT, the mutant MA lines exhibited similar 
mutation frequencies and specific mutational landscapes (compare Fig. 1C and 1D, SI 
Appendix, Fig. S2A) but revealed the presence of numerous LOH regions, robustly defined to 
involve ≥3 adjacent markers (Fig. 4A, SI Appendix, Fig. S5 to 9). In WT and pif1, LOHs were 
rare (0.09 and 0.12 LOH/clone/passage, respectively) (SI Appendix, Fig. S7 and 8). It was 
modestly increased in rad51 (0.18 LOH/clone/passage), while many arose in tsa1 and rad27 
(1.2 and 2.5 LOH/clone/passage corresponding to a 12.7- and 27.3-fold increase, 
respectively). In numerous instances, these LOH events involved several chromosomes in the 
same clone (Fig. 4B; SI Appendix, Fig. S5A and 6A). Considering all the clones, the LOHs 
covered a large fraction of the genome in tsa1 and almost all the genome in rad27 (Fig. 4C). 
Regarding the occurrence of homozygous mutations, again this was most frequent in tsa1 and 
rad27 cells (Fig. 4D; Dataset S10). Notably, 16/22 in tsa1 and 95/114 in rad27 were located 
in LOH regions with 2 copies of the chromosome (Fig. 4C, E;  Datasets 3 and 4), consistent 
with the hypothesis that along the cell lineage, mutations arose as heterozygous and passively 
became homozygous as part of a subsequent overlapping LOH event (Fig. 4E). Among the 
remaining events, 2 cases in tsa1 and 10 cases in rad27, resulted from the occurrence of a de 
novo mutation on one homolog and an overlapping de novo deletion on the homolog (Fig. 3B, 
Fig. 4D; Dataset S4), as frequently found in tumor cells that carried a germline susceptibility 
mutation and then acquired a secondary somatic deletion on the homologous chromosome 
(45). Thus, the highly mutagenic tsa1 and rad27 strains stimulated SNPs and LOH events, a 
dual signature that accelerate and enlarge the spectrum of genome modifications. 
 
Distributions and mechanisms of interstitial and terminal LOHs 
 In tsa1 and rad27, the majority of LOHs were interstitial (81% and 76%, respectively; Fig. 
4F) with a length varying from 33 bp to 419 kb and 17 bp to 846 kb, respectively (Dataset 
S12). The remaining LOHs were terminal, with lengths varying from 659 bp to 1,052 kb in 
tsa1 and 55 bp to 1,079 kb in rad27 (Dataset S12). Globally, the interstitial LOHs are shorter 
than the terminal LOH (SI Appendix, Fig. S10A), consistent with their origin resulting from 
gene conversion like events and/or double crossovers rather than a single crossover. The 
LOHs size ranges were similar to those observed in a previous study (46). In both mutants, 
the LOHs were from one or the other parental haplotype, with a slight BY vs. SK1 excess 
genotype (58 and 55%, respectively). Due to the extended polymorphism of the BY and SK1 
genomes, this slight bias may result from intrinsic and emerging lethal allele incompatibilities 
when part of the genome become homozygous, a somatic manifestation of the spore 
inviability observed in the SK1/S288C haploid segregants (47, 48). The annotation of the 
LOH breakpoint regions did not localize to specific functional elements except in pif1 where 
they often were in proximity to a LTR/Ty region and/or the rDNA locus (SI Appendix, Fig. 
S10B). Thus, after only 25 single bottleneck passages, the stimulation of LOH created mosaic 
diploid genomes (Fig. 4C and SI Appendix, Fig. S5A and 6A) that reached 4.7-28.9% 
homozygosity per clone in tsa1, and 26.6-60.7% in rad27.  
  The formation of terminal LOHs is a hallmark of break-induced-replication (BIR) (49, 50), 
whereas both terminal and interstitial LOHs can result from mitotic crossover recombination 
and/or gene conversion. Since BIR specifically depends on the activity of POL32 and PIF1 
(51–54), we examined the effect of deleting these genes in the tsa1 mutant (Dataset S1). 
Similar to tsa1, the tsa1 pol32 and tsa1 pif1 SK1/BY MA lines displayed increased base 
substitutions (13.9 and 32.3-fold vs. WT, respectively) and LOHs (11.1- and 17.5- fold vs 
WT, respectively). The absolute frequency of terminal LOHs, however, was not significantly 
reduced (0.22, 0.25 and 0.29 /clone/passage in tsa1, tsa1 pol32 and tsa1 pif1, respectively) 
and the large excess of interstitial vs. terminal LOHs was retained (81%, 72%, 81% in tsa1, 
tsa1 pol32 and tsa1 pif1, respectively) (Fig. 4F). Thus, such LOHs result from stimulation of 
mitotic recombination, rather than BIR, explaining the synthetic lethality of the tsa1 rad51 
double mutant (42). We examined the length of the terminal LOH in the tsa1, tsa1 pif1 and 
tsa1 pol32 (SI Appendix, Fig. S10A) and observed no significant difference between tsa1 and 
tsa1 pif1 but a significant increase of terminal LOH length in tsa1 pol32 suggesting a role of 
Pol32 in the distribution of the initiating events although the annotation of the terminal LOH 
breakpoints in the three tsa1 strain is similar (SI Appendix, Fig. S10C). The contribution of 
BIR in the stimulation of the rad27 LOHs could not be examined due to the synthetic lethality 
of the rad27 pol32 double mutant (55). Nevertheless, the synthetic lethality of rad27 (alike 
tsa1) with rad51 (55), suggests that rad27 LOHs also largely result from inter-homolog 
mitotic recombination, albeit not necessarily stimulated by identical initiating lesion(s).  
 
Trajectory of base substitution and LOH along lineages  
To determine trajectories of mutation accumulation, we sequenced the genomes of the tsa1 
clone N and rad27 clone C cells collected at each of the 25 bottleneck passages (SI Appendix, 
Fig. S5B and 6B, and Movies S1 and S2, respectively). In both mutants, the accumulation of 
heterozygous mutations (SNPs and small Indels) appeared essentially regular; in tsa1, 15/25 
passages yielded one or two de novo mutations and 7/25 passages three or five mutations; in 
rad27, 7/25 passages yielded one or two mutations but a majority of passages (15/25) yielded 
three to nine mutations. These multiple mutation events did not necessarily arise within one 
cell division, since in our experimental protocol, each bottleneck passage correspond to ~25 
generations (Fig. 5, Datasets 13-14). Also, to note, 3/16 tsa1 pol32 clones (C12, D12, O12) 
that exhibited a LOH in both MSH2 and PMS1 regions showed a higher number of de novo 
mutations (34, 30 and 46 mutations, respectively) compared to 19 mutations in average in the 
other clones. This can be explained by the presence of MLH1-D161 homozygous allele from 
BY and PMS1-K818 homozygous allele from SK1, previously reported to confer a mismatch 
repair deficient phenotype in haploid strains (56).  This case illustrates the occurrence of a 
secondary mutator phenotype occurring during the clonal drift.  
       Along the lineages, several de novo heterozygous mutations (2/45 and 9/90 in tsa1 and 
rad27, respectively) chronologically became homozygous in a single bottleneck passage as a 
consequence of an overlapping LOH, while others (1/45 and 6/90 in tsa1 and rad27, 
respectively) were eliminated in favour of the WT allele (Fig. 6A-B; Dataset S15-16, Movies 
S1-2, http://xfer.curie.fr/get/i2FK7JDkQgs/SupAnim.zip). This opposite outcome is explained 
by the occurrence of an overlapping LOH mediated by an inter-homolog recombination event, 
followed by the segregation of the non-sister chromatids carrying both WT or mutant allele in 
the daughter cells (Fig. 4E). Multiple fixation and elimination of mutations, as well as 
extension of LOH tracts, also occurred in a single passage (Fig. 6C). The biological impact of 
such a mutator phenotype is functionally important because during cell proliferation, 
stimulation of LOHs will allow the phenotypic expression of recessive de novo mutations 
when fixed but also erase heterozygous mutations that transiently occurred during clonal 
evolution. In cancer settings, such a mutator phenotype could be initially advantageous to 
enhance the genetic diversity to stimulate proliferation of pre-tumoral cells, while afterwards 
the restoration of the WT allele could be beneficial to restore cell physiology. A similar 
scenario for a dominant mutator gene mutation will permit a wave of cell genetic 
diversification and its subsequent elimination, avoiding the accumulation of additional 
disadvantageous mutations (2, 57, 58). Retrospectively, in contrast to reversible epigenetic 
events that may not leave long term molecular scars, a transient mutation can remain 
detectable as a LOH event. This “archaeological signature” raises the prospect that one or 
more of LOH embedded genes may have been transiently mutated during the evolutionary 
history of a cell lineage. 
 
Conclusion 
The mutation of genes controlling genome stability and/or the epigenetic deregulation of their 
expression  contributes to create the genetic diversity on which the Darwinian selection can 
act. Our study has illustrated the large variety of mutational profiles generated by genetic 
deficiencies in genome-stability genes, and described the dynamics of de novo mutations and 
genome rearrangements (fixation and disappearance) during vegetative growth. This 
knowledge suggests ways to mechanistically interpret tumor cells genome evolution and 
genetic sensitivity (6–11, 59, 60), as well as genome evolution in species (1–3). On the 
evolutionary scale, impaired function of genes such as RAD27/FEN1 and TSA1/PRDX1 may 
allow the generation of genetic diversity, including occasional beneficial mutations (or 
suppressors of less fit mutant states), while additional recombination-dependent changes may 
be beneficial to resolve burdens of allelic incompatibilities in polymorphic and hybrid 
species. In the future, extending analyses of “mutomes” in yeast should allow refinement of 
the mutator scope of additional genome maintenance genes and graph the complexity of the 
genes/pathways and their interactions (4). It will also likely suggest how related phenomena 
operate in other organisms such as Caenorhabditis elegans (61) and engineered human cell 
lines (62) amenable to “mutome” analyses.   
 
Materials and Methods 
Strains and mutation accumulation lines. Mutations accumulations lines were obtained 
from BY or BY/SK1 diploid mutants carrying homozygous deletions of the genes listed in 
Fig. 1A. The details of the strain constructions are described in SI Appendix and the complete 
strain genotypes are listed in Dataset S1. All strain constructions were checked by PCR,  
Southern blot or Sanger sequencing. Proper gene deletions were confirmed by the lack of read 
coverage upon whole genome sequencing of the parent and MA lines. 
Generation of mutation accumulation lines. The mutation accumulation lines (MA) were 
obtained as described in (23). Briefly, 4 to 16 colonies of each diploid parental strain was 
subjected to 12 to 100 single-cell bottlenecks (Datasets S2 and 10). One single-cell bottleneck 
is performed by picking one colony of average size and by streaking it to individual colonies 
on YPD plate (1% yeast extract, 2% peptone, 2% dextrose), incubated for 3 days of growth at 
30°. 
 
Mutation calling, LOH detection and mutational signatures. Illumina whole-genome 
sequencing were performed on parents and mutations accumulation lines. The paired-end 
reads were aligned on R64-1-1 S288c SGD reference sequence 
(http://www.yeastgenome.org). Our analysis pipeline outlined in S1 Appendix, Fig. S1 
allowed the detection of all kind of mutations and genome rearrangements and ploidy 
variations. The base substitution mutational signatures were extracted using the 
R/Bioconductor MutationalPatterns package (63). In the hybrid strains, the LOH regions were 
detected by genotyping the 53,523 polymorphisms that distinguish the BY and SK1 strain 
backgrounds (Dataset S11). The LOH were robustly defined as regions showing at least 3 
consecutive homozygous markers of the same haplotype (See details in SI Appendix). 
Canavanine mutator assay. To measure the rate of mutations in the CAN1 gene, the 
occurrence of canavanine resistant colonies in BY haploids were measured as previously 
described (64). The fluctuation test assays were performed from 5 independent cultures. The 
mutation rate was calculated using bz-rates (65) tool (http://www.lcqb.upmc.fr/bzrates). 
Reported mutation rates are the average of at least 3 experiments. 
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Figures legends 
Fig. 1. Mutational landscapes. (A) List of genes studied and their functions. (B) 
Experimental strategy to generate mutation accumulation lines. The WT diploid strains 
(BY/BY or SK1/BY background) were deleted for both copies (∆/∆) of the potentially 
mutator gene(s). Then, 4-16 independent clones of the WT and ∆/∆ diploids were grown 
mitotically and derived for up to 100 single-cell bottlenecks passages on YPD rich medium at 
30°C (23). The genome of the resulting accumulation lines was individually sequenced by 
NGS and the reads analysed for detection of de novo mutations and genome rearrangements 
(see SI Appendix, Materials and Methods and Fig. S1). (C-D) Mutational profiles in BY/BY 
and SK1/BY strains, respectively. N. of mutations: total number of de novo mutations 
detected in each strain, including single nucleotide variants (SNP), small indels, multi-
nucleotide variant (MNP), "complex" events referring to combination of SNPs and small 
Indels, chromosome aneuploidies and structural variants (SV) (large deletions/insertions). The 
SNP and small indels comprise both heterozygous (allelic ratio ~0.5) and apparently 
homozygous events (allelic ratio ~1.0). For each mutant, the class of mutator profile, the 
number of clones, passages and mutations are indicated. The mean number of mutations per 
clone normalized to the number of passages and standard error are shown. The mutational 
fold variation compared to the corresponding WT is shown into parenthesis. Mann-Whitney-
Wilcoxon test was performed to compare each mutant with  WT (ns: not significant, **p-
value<0.01).   
 
Fig. 2. Mutational signatures and Pol -dependent mutagenesis.  (A) Mutational profiles of 
WT, tsa1, rad51, msh2 and rad27 mutants obtained with MutationalPatterns (63). N: number 
of base substitutions examined (sum of heterozygous and homozygous SNP found in BY and 
SK1/BY backgrounds). Count for tsa1 is the sum of SNPs observed in the tsa1∆/∆, tsa1∆/∆ 
pol32∆/∆ and tsa1∆/∆ pif1∆/∆ strains (BY and SK1/BY backgrounds). *: WT data includes 
our data (110 SNPs) and 719 de novo SNP detected  by Sharp et al. (18) in another WT 
diploid S. cerevisiae MA lines. (B) Relative contribution of COSMIC signatures in WT, tsa1, 
rad51,  msh2 and rad27 mutational profiles (dataset as in A), calculated with 
MutationalPatterns (63). **: data from Lujan et al. (21). (C) Canavanine resistance (CANR) 
assay of WT and haploid mutants (BY background). The mutation rate is the average of at 
least 3 fluctuation tests, each made with 5 independent cultures. It is calculated according to 
Reenan and Kolodner (64), using bz-rates web-tool (http://www.lcqb.upmc.fr/bzrates (65).  
Error bars are standard deviation. 
 
Fig. 3. Occurrence and potential origin of «homozygous» de novo mutations. (A) Allelic 
ratio of mutations from MA lines (BY and SK1/BY backgrounds). Sum of heterozygous 
(allelic ratio ~0.5) or homozygous (allelic ratio ~1.0) SNPs, small indels, MNP and complex 
mutations. Copy number is calculated with Control-FREEC (66). (B) Molecular events 
leading to de novo mutations with an allelic ratio of ~1.0, associated or not with local or 
chromosomal copy number variation.  
 
Fig. 4. Detection of LOHs in the SK1/BY MA lines. (A) Total number of LOH regions per 
clone normalized per passage. (B) Examples of allelic profiles in a WT, tsa1 and rad27 MA 
lines at final passage 25. The genotype of the 53,523 SK1 vs. BY polymorphisms are plotted 
on the 16 chromosomes. A minimum of 3 adjacent markers of the same parental genotype 
was retained to define the local haplotype (see SI Appendix) being either heterozygous 
SK1/BY (grey), homozygous SK1 (blue) or homozygous BY (red). The triangles indicate the 
location of the heterozygous (black) or “homozygous” (purple) de novo mutations (SNP, 
MNP, complex and small indels, see SI Appendix, Materials and Methods). (C) Heatmap of 
the genome wide occurrence of homozygosity among SK1/BY tsa1 and rad27 clones. (D) 
Number of homozygous mutations originated from mitotic recombination or BIR (labelled 
REC), chromosome loss or deletion identified in the SK1/BY mutants, being located or not in 
a LOH region. (E) Two steps occurrence of homozygous de novo mutations upon inter-
homolog mitotic recombination or BIR. (F) Percentage of interstitial and terminal LOH–REC 
tracks, N: Total number of LOH events.  
 
Fig. 5. Dynamics of LOH formation in the tsa1 clone N and rad27 clone C lineages.  
Trajectory of the de novo LOH events in the SK1/BY tsa1 clone N (left) and rad27 clone C 
(right) from passage 1 to 25. First column is the parental clone. Grey: SK1/BY heterozygous 
markers, red: homozygous BY markers; blue: SK1 homozygous markers. In rad27, the 
passages 2 and 3 were mosaic and are shown in SI Appendix, Fig. S6; passage 8 is omitted 
because the cells could not be recovered after storage.  
 
Fig. 6. Dynamics of de novo mutations and LOH formation in the tsa1 clone N and rad27 
clone C lineages. (A-B) Trajectory and heterozygous (grey) vs. homozygous (purple) status of 
the 45 de novo mutations detected in the tsa1 clone N and of the 90 de novo mutations 
detected in the rad27 clone C, respectively, from passage 1 to 25. Green: mutation found in a 
3 copy-number region and exhibiting a 1/3 allelic ratio.  The coordinates of the mutations 
(chromosome number, position, nucleotides in the parental BY reference, nucleotides in the 
mutant clone) are shown. Green star:  heterozygous mutation that became homozygous; 
Orange star: mutations eliminated in a single passage. Numbers in parenthesis refer to 
chromosomes shown in (C). (C), Examples of fixation and elimination of mutations upon 
LOH and of mutations associated with the occurrence or extension of a nearby LOH event. 
































Deleted yeast gene Human ortholog Biological function 
RAD27 FEN1 Replication/repair Flap endonuclease involved in DNA replication and long patch base excision repair 
POL32 POLD3 Replication Subunit of DNA polymerase δ 
MRE11 hMRE11 Recombination/repair Protein involved in DSB repair. NHEJ and telomere metabolism 
RAD51 hRAD51 Recombination Strand exchange protein involved in recombinational repair of DNA double-strand breaks 
LIG4 hLIG4 Non-homologous end-joining DNA ligase required for NHEJ 
MSH2 hMSH2 Mismatch repair Protein involved  in mismatch repair process 
TSA1 PRDX1 Oxydative stress response Thioredoxin peroxidase 
CAC1 and CAC3 CAF-1 Chromatin-assembly factor Nucleosome deposition 
PIF1 hPIF1 Telomere/mitochondria/ G quadruplex 5’-3’ helicase; telomerase inhibitor; Involved in maintenance of mitochondrial genome. processing of G-quadruplex secondary structures and DNA synthesis 
THO2 hTHO2 Transcription Subunit of the THO complex involved in transcriptional elongation-associated recombination 
CLB5 CCNB1 Cell cycle / Chromosome segregation B-type cyclin involved in DNA replication during S-phase 












4 to 16 independant clones 
∆/∆ 
∆/∆ ∆/∆ ∆/∆ ∆/∆ 
∆/∆ ∆/∆ ∆/∆ ∆/∆ 
Identification of de novo mutations. genome 


































24 25 76 0.13 ± 0.02 (1) 
8 25 23 0.12 ± 0.02 (0.9)ns 
16 25 53 0.13 ± 0.02 (1)ns 
16 12 26 0.14 ± 0.03 (1.1)ns 
2 
16 25 1043 2.61 ± 0.07 (20.6)** 
8 25 345 1.73 ± 0.24 (13.6)** 
3 16 25 4218 10.55 ± 0.45 (83.3)**
4 
8 25 98 0.49 ± 0.06 (3.9)** 
16 12 67 0.35 ± 0.04 (2.8)** 
8 25 56 0.28 ± 0.03 (2.2)** 
4 100 118 0.30 ± 0.03 (2.3)** 
5 8 25 413 2.07 ± 0.20 (16.3)** 
































1 16 25 59 0.15 ± 0.02 (1) 
2 
16 12 471 2.45 ± 0.16 (16.6)**
15 25 580 1.55 ± 0.06 (10.5)** 
16 12 405 2.11 ± 0.21 (14.3)** 
15 12 711 3.95 ± 0.20 (26.8)** 
5 16 25 898 2.25 ± 0.15 (15.2)** 
6 16 12 79 0.41 ± 0.05 (2.8)** 
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Number of heterozygous mutations Number of homozygous mutations 
Parental strain: 
1 alternate allele 
+  reference allele 
2 alternate alleles 
 + no reference allele 1 alternate allele 
+ no reference 
Copy 
number 
2 <2 >2 
WT 125 0 3 (2.3%) 3 0 0 
rad27 1045 9 163 (13.4%) 141 16 6 
tsa1 848 1 60 (6.6%) 54 2 4 
pif1 116 0 2 (1.7%) 1 1 0 
clb5 82 0 1 (1.2%) 1 0 0 
mre11 44 0 5 (10.2%) 4 1 0 
cac1 cac3 21 0 2 (8.7%) 2 0 0 
pol32 25 0 1 (3.8%) 1 0 0 
sic1 34 0 1 (2.9%) 1 0 0 
msh2 2801 48 23 (0.8%) 22 1 0 
lig4 53 0 0 (0.0%) 0 0 0 
rad51 1421 2 18 (1.2%) 7 11 0 
tho2 107 0 5 (4.5%) 4 1 0 
tsa1 pol32 323 1 40 (11.0%) 17 20 3 













































 WT clone E25 





























          N 37 958 13 21 437 280 169 











in LOH region 






WT 2 0 0 0 0 (0%) 2 (100%) 
rad27 114 95 3 10 108 (95%) 6 (5%) 
rad51 11 3 5 0 8 (73%) 3 (27%) 
pif1 1 0 1 0 1  (100%) 0 (0%) 
tsa1 22 16 0 2 18 (82%) 4 (18%) 
tsa1 pif1 27 22 0 3 25 (93%) 2 (7%) 
tsa1 pol32 40 20 17 2 39 (98%) 1 (3%) 
 


